1Maddrey WC. Hepatitis B: an important public health issue. J Med Virol,2000,61:362-366.
2Ikeda K, Saitoh S, Suzuki Y, et al. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation in 2215 patients. J Hepatol,1998,28:930-938.
3Fattovich G, Brollo L, Alberti A, et al. Long term follow-up of anti-HBe positive chronic hepatitis B. Hepatology,1988,8:1651-1654.
4Liaw YF, Lin DY, Chen TJ, et al. Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Liver,1989,9:235-241.
5Fattovich G, Pantalena M, Zagni I, et al. Effect of hepatitis B and C virus infection on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am J Gastroenterol,2002,97:2886-2895.
6de Jongh FE, Janssen HL, de Man RA, et al. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology,1992,103:1630-1635.
7Hui AY, Chan HL, Leung NW, et al. Survival and prognostic indicators in hepatitis B virus-related cirrhosis after onset of hepatic decompensation. J Clin Gastroenterol,2002,34:569-572.
8Keeffe EB. Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology,2001,120:749-762.
9Hoofnagle JH, Di Bisceglie AM, Waggoner JG, et al. Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology,1993,104:1116-1121.
10Perrillo R, Tamburro C, Regenstein F, et al. Low dose, titratable interferon alfa in decompensated liver disease caused by chronic infection with hepatitis B virus. Gastroenterology,1995,109:908-916.
